Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients. (2023). Canadian Dermatology Today, 4(3), 5–10. https://canadiandermatologytoday.com/article/view/4-3-fournier